James C. Gilbert

First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers

James C. Gilbert, Tia DeFeo-Fraulini, Renta Hutabarat et al. · Circulation · 2007 · 282 citations · Full text

Appendicitis 2000: Variability in practice, outcomes, and resource utilization at thirty pediatric hospitals

Kurt D. Newman, Todd A. Ponsky, Kory Kittle et al. · Journal of Pediatric Surgery · 2003 · 237 citations

Appendicitis 2000, Thirty Pediatric Hospitals, Pediatric Emergency Medicine +11

Quantitation of transplanted hepatic mass necessary to cure the gunn rat model of hyperbilirubinemia

Katsuhiro Asonuma, James C. Gilbert, James E. Stein et al. · Journal of Pediatric Surgery · 1992 · 111 citations

Gunn Rat Model, Transplantation, Hepatology +10

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial

Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer et al. · Blood · 2018 · 108 citations · Full text

The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale

Robert P. Giugliano, L. Kristin Newby, Robert A. Harrington et al. · American Heart Journal · 2005 · 88 citations

Thrombosis, Cardiovascular Disease, Coronary Artery Disease +10